Orly Mishan joined Bain Capital Life Sciences in 2017. Prior to joining Bain Capital, she was the Vice President of Corporate Strategy & Development at Biogen. Before Biogen, Ms. Mishan spent a decade at Boston Scientific driving strategy, business development, restructuring and product development. Prior to this, Ms. Mishan led business and product development at a venture-funded diagnostics company, Senseonics. In 1997, she joined Pfizer where she was the commercial lead on product development for products in diabetes and Metabolic diseases and helped drive transactions across multiple therapeutic areas. Ms. Mishan began her career at McKinsey & Company in New York and Paris and focused on strategy and M&A for large pharma clients during her time at McKinsey in Boston.
Ms. Mishan received a BA in Economics and Political Science from Columbia College.